levosimendan group:levosimendan

2 trials

Sponsors

Qilu Hospital of Shandong University, The People’s Hospital of Guangxi Zhuang Autonomous Region

Conditions

Cardiogenic Shock Complicated by Acute Myocardial InfarctionSarcopenia with heart failure with reduced ejection fraction

Phase 4

Levosimendan improves exercise tolerance in Sarcopenia with heart failure with reduced ejection fraction.

RecruitingChiCTR2100041785

Qilu Hospital of Shandong UniversitySarcopenia with heart failure with reduced ejection fraction

Start: 2021-02-01Updated: 2021-03-22

Unknown Phase

The Effectiveness of Levosimendan on Veno-Arterial Extracorporeal Membrane Oxygenation Management of Cardiogenic Shock Complicated by Acute Myocardial Infarction: A prospective randomized controlled trial

Active, not recruitingChiCTR2500114346

The People’s Hospital of Guangxi Zhuang Autonomous RegionCardiogenic Shock Complicated by Acute Myocardial Infarction

Start: 2026-01-01Updated: 2025-12-15